Delivery Order SPE2DB20D2104-SPE2DB22FS82P
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,377.72, is a delivery order for the pharmaceutical product Vascepa 1 GM Capsule 120S. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., both of which are registered in the System for Award Management (SAM.gov) as for-profit organizations....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM Capsule 120S. The contract, valued at $27,009.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This federal contract award, valued at $1,335.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This federal contract award is a $1,683.46 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vascepa 1 GM capsules, a cardiovascular medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,023.88, is a delivery order for the supply of the medication Vascepa 1 GM Capsule 120S. The contract has a firm fixed price and an ultimate completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $15,047.32 delivery order contract is for the supply of VASCEPA 1 GM capsules, a cardiovascular medication. The contract is a firm fixed-price, Delivery Order type with an ultimate completion date of October 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
- This federal contract award is for the delivery of the pharmaceutical product Vascepa 1 GM Capsule 120S to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $4,584.29 firm fixed-price delivery order was awarded on March 31, 2022 to the prime contractor Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,539.90 with a firm fixed price, and an ultimate completion date of September 29, 2023. The award is for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,701.49 Firm Fixed Price delivery order is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS82PDelivery Order
This federal contract award, valued at $31,153.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the drug Vascepa, a 1 GM capsule provided in 120-count packages. The award does not have a set-aside designation, indicating it was made through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both companies are for-profit organizations that serve as critical suppliers of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. In addition to this specific delivery order, Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical commodities to support military treatment facilities and veterans' healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 5/24/22 |